CN109021331A - Medical latex film and preparation method thereof - Google Patents

Medical latex film and preparation method thereof Download PDF

Info

Publication number
CN109021331A
CN109021331A CN201810746351.5A CN201810746351A CN109021331A CN 109021331 A CN109021331 A CN 109021331A CN 201810746351 A CN201810746351 A CN 201810746351A CN 109021331 A CN109021331 A CN 109021331A
Authority
CN
China
Prior art keywords
parts
medical latex
latex film
film
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201810746351.5A
Other languages
Chinese (zh)
Inventor
李苏杨
徐勤霞
成清明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Bec Biological Technology Co Ltd
Original Assignee
Suzhou Bec Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Bec Biological Technology Co Ltd filed Critical Suzhou Bec Biological Technology Co Ltd
Priority to CN201810746351.5A priority Critical patent/CN109021331A/en
Publication of CN109021331A publication Critical patent/CN109021331A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2307/00Characterised by the use of natural rubber
    • C08J2307/02Latex
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2475/00Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
    • C08J2475/04Polyurethanes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K13/00Use of mixtures of ingredients not covered by one single of the preceding main groups, each of these compounds being essential
    • C08K13/02Organic and inorganic ingredients
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/02Elements
    • C08K3/08Metals
    • C08K2003/0806Silver
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K2201/00Specific properties of additives
    • C08K2201/011Nanostructured additives
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/09Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/09Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • C08K5/092Polycarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/15Heterocyclic compounds having oxygen in the ring
    • C08K5/151Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
    • C08K5/1545Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

The present invention provides a kind of medical latex films and preparation method thereof, and medical latex film includes following component: 0.01-0.05 parts of nano silver, 0.1-1 parts of water soluble chitosan, 0.1-1 parts of antioxidant, 2-5 parts of antilubricant, 5-10 parts of aqueous polyurethane, 80-90 parts of natural emulsion.Wherein, the antioxidant is tea polyphenols, and antilubricant is tartaric acid.Tea polyphenols have the function of very strong elimination harmful free radicals, and antioxidation is clearly.Tartaric acid is the various organic acids extracted from fruit, is the effective component being present in a variety of natural fruits or Yoghourt, harmless, and is had effects that significant anti-skidding.The present invention also provides a kind of preparation methods of medical latex film.Medical latex film of the invention has the function of inoxidizability and anti-skidding, and has bacteriostasis.

Description

Medical latex film and preparation method thereof
Technical field
The present invention relates to field of material technology more particularly to a kind of medical latex film and preparation method thereof.
Background technique
Heveatex is a kind of sticky milky white liquid, and for appearance as milk, it is rubber particles in Nearly neutral medium Milky aqueous dispersion, in air due to the effect of oxygen and microorganism, latex acidity increases, 2-12h can natural coagulation, be Natural coagulation is prevented, a certain amount of ammonia solution need to be added as protective agent.Heveatex belongs to the thermoplasticity synthesis tree of rubber Rouge its main feature is that filming performance is good when high resiliency, bonding, glue film is imbued with flexibility, thus makes glue film have excellent resistance to bend Flexible, shock resistance and creep resistance, suitable for the bonding between the bonding and different thermal expansion coefficient material of dynamic lower component. The mankind long ago begin to the base-material for using Heveatex as adhesive.The characteristics of Heveatex, is that solid content is high, forms a film Property is good, can arbitrarily adjust viscosity etc., but its resistance to ag(e)ing, oil resistivity, chemical resistance, temperature tolerance, frost resistance are poor.Natural gum The cohesive force of cream is big, from stickiness height, but since its macromolecular chain polarity is small, therefore and the big adherend of adherend, especially polarity Tackness is poor.A certain amount of tackifier, such as vegetable oil, mineral oil, terpene resin, rosin, casein, starch, dextrin is added, The polarity of Heveatex will be improved significantly, and softened, thus improve its stickiness and the tackness to adherend.If Heveatex and methyl methacrylate are grafted, polarity of chain can also be increased and improve tackness.
Medical latex film using natural emulsion as main component, therefore how to improve medical latex material anti-microbial property, Antioxygenic property and non-skid property are one of the problems that this field faces.
Summary of the invention
The purpose of the present invention is to provide a kind of medical latex films and preparation method thereof, can significantly improve medical latex Anti-microbial property, antioxygenic property and the non-skid property of material.
To reach this purpose, the present invention adds tea polyphenols, and tea polyphenols have the function of very strong elimination harmful free radicals, Antioxidation is clearly.The effects of being embodied in anti-aging and radiation resistance and antibacterial, sterilization.Tea polyphenols have very strong Antioxidation, it is 6-7 times of VE, the 5- of VC that oxidation resistance, which is artificial synthesized antioxidant BHT, 4-6 times of BHA, 10 times, and dosage is few, and the potential toxic side effect without synthetic;And tea polyphenols can effectively stop radioactive substance intrusion bone Marrow, and strontium 90 and Co 60 can be made to excrete rapidly, " radiation jinx " is described as by health and medical field.
Silver ion and bacterium haptoreaction, cause cell proper constituent to be destroyed or generate dysfunction and dead.When micro- When amount silver ion and microbial cell meet, due to silver ion oxidation-reduction potential with higher (± 0.798V, 25 DEG C), and The latter has negative electrical charge, by Coulomb attraction, the two is made to be closely linked, and silver ion can also the entrance of penetrating cell wall It in bacterial body, and is reacted with the sulfydryl in bacterium, makes protein coagulating, destroy the activity of cell synzyme, make cell loss point Split proliferative capacity and dead, while silver ion can also destroy microorganism electron-transport system, respiratory system, substance delivery system, Cause microbial cell dead, plays bactericidal effect.Meanwhile under the action of light, micro silver ion can be played in catalytic activity The effect of the heart can activate the oxygen in air or water, generate hydroxyl radical free radical and active oxygen ion, they have very strong energy of oxidation Power can destroy the proliferative capacity of microbial cell, inhibit or kill bacterium, play bactericidal effect.
The histoorgan and cell of chitosan and human body have good biocompatibility, and the special function with antibacterial anti-inflammatory Energy.The present invention utilizes heterocoagulation blend method, and water soluble chitosan is introduced into natural emulsion system;And aqueous polyurethane with Water is solvent, has many advantages, such as that pollution-free, safe and reliable, good mechanical performance, compatibility are good, easily modified.
Tartaric acid, as its name suggests, the various organic acids exactly extracted from fruit are to be present in a variety of natural fruits or Yoghourt In effective component.Comprising grape acid, malic acid, citric acid and lactic acid etc., because most of by refining in fruit, therefore claim tartaric acid. It is wherein most wide with the Glycolic acid utilization refined from sugarcane, it is harmless, and have effects that significant anti-skidding.
Specifically, the invention adopts the following technical scheme:
On the one hand, a kind of medical latex film, including following component:
0.01-0.05 parts of nano silver,
0.1-1 parts of water soluble chitosan,
0.1-1 parts of antioxidant,
2-5 parts of antilubricant,
5-10 parts of aqueous polyurethane,
80-90 parts of natural emulsion.
Further, antioxidant is tea polyphenols, and antilubricant is tartaric acid.
Further, the dosage of nano silver is 0.03 part.
Further, the dosage of water soluble chitosan is 0.5 part.
Further, the dosage of aqueous polyurethane is 8 parts.
Further, the dosage of antioxidant is 0.5 part.
Further, the dosage of natural emulsion is 85 parts.
Still further, the content of catechin is 50%-70% in tea polyphenols.
Preferably, the content of catechin is 55%-65% in tea polyphenols.
Further, the dosage of antilubricant is 3 parts.
Still further, the content of Glycolic acid is 40%-60% in tartaric acid.
Preferably, the content of Glycolic acid is 55%-60% in tartaric acid.
Another aspect, a kind of preparation method of medical latex film comprising following steps:
(1) each component is put into reaction kettle, 90-100 DEG C is heated in nitrogen atmosphere, 100-120r/min's It is stirred continuously under revolving speed, reacts 2-3h, obtain preform;
(2) by preform made from step (1) be sent into double screw extruder, 175-185 DEG C of extrusion temperature, screw speed 40-45Hz, twin-screw extrusion batten is water cooled, air-dried, pelletizing, obtains master batch;
(3) master batch obtained by step (2) is squeezed out into blown film in plastic film blowing machine to get medical film is arrived.
To sum up, medical latex film of the invention has the function of inoxidizability and anti-skidding, and has bacteriostasis, with Traditional medical latex film is compared, and material therefor of the present invention is nontoxic and pollution-free, harmless.
Specific embodiment
Present invention is further described in detail combined with specific embodiments below.It should be understood that following embodiment is only used In illustrating the present invention, limitation of the scope of the invention but should not be understood as.
Embodiment 1
A kind of medical latex film, the ingredient including following parts by weight:
Nano silver 0.01kg;
Water soluble chitosan 0.1kg;
Antioxidant 0.1kg;
Antilubricant 2kg;
Aqueous polyurethane 5kg;
Natural emulsion 80kg.
The preparation method of medical latex film the following steps are included:
(1) each component is put into reaction kettle, 90 DEG C is heated in nitrogen atmosphere, under the revolving speed of 100r/min not Disconnected stirring, reacts 2h, obtains preform;
(2) by preform made from step (1) be sent into double screw extruder, 175 DEG C of extrusion temperature, screw speed 40- 45Hz, twin-screw extrusion batten is water cooled, air-dried, pelletizing, obtains master batch;
(3) master batch obtained by step (2) is squeezed out into blown film in plastic film blowing machine to get medical film is arrived.
Embodiment 2
A kind of medical latex film, including following component:
Nano silver 0.05kg;
Water soluble chitosan 1kg;
Antioxidant 1kg;
Antilubricant 5kg;
Aqueous polyurethane 10kg;
Natural emulsion 90kg.
The preparation method of medical latex film the following steps are included:
(1) each component is put into reaction kettle, 100 DEG C is heated in nitrogen atmosphere, under the revolving speed of 120r/min It is stirred continuously, reacts 3h, obtain preform;
(2) by preform made from step (1) be sent into double screw extruder, 185 DEG C of extrusion temperature, screw speed 40- 45Hz, twin-screw extrusion batten is water cooled, air-dried, pelletizing, obtains master batch;
(3) master batch obtained by step (2) is squeezed out into blown film in plastic film blowing machine to get medical film is arrived.
Embodiment 3
A kind of medical latex film, including following component:
Nano silver 0.03kg;
Water soluble chitosan 0.5kg;
Antioxidant 0.5kg;
Antilubricant 3kg;
Aqueous polyurethane 8kg;
85 parts of natural emulsion.
The preparation method of medical latex film the following steps are included:
(1) each component is put into reaction kettle, 100 DEG C is heated in nitrogen atmosphere, under the revolving speed of 110r/min It is stirred continuously, reacts 3h, obtain preform;
(2) by preform made from step (1) be sent into double screw extruder, 180 DEG C of extrusion temperature, screw speed 40- 45Hz, twin-screw extrusion batten is water cooled, air-dried, pelletizing, obtains master batch;
(3) master batch obtained by step (2) is squeezed out into blown film in plastic film blowing machine to get medical film is arrived.
The above is only a preferred embodiment of the present invention, it is not intended to restrict the invention, it is noted that for this skill For the those of ordinary skill in art field, without departing from the technical principles of the invention, can also make it is several improvement and Modification, these improvements and modifications also should be regarded as protection scope of the present invention.

Claims (10)

1. a kind of medical latex film, which is characterized in that the ingredient including following parts by weight:
0.01-0.05 parts of nano silver;
0.1-1 parts of water soluble chitosan;
0.1-1 parts of antioxidant;
2-5 parts of antilubricant;
5-10 parts of aqueous polyurethane
80-90 parts of natural emulsion;
Wherein, the antioxidant is tea polyphenols, and antilubricant is tartaric acid.
2. medical latex film as described in claim 1, which is characterized in that the dosage of the nano silver is 0.03 part.
3. medical latex film as described in claim 1, which is characterized in that the dosage of the water soluble chitosan is 0.5 part.
4. medical latex film as described in claim 1, which is characterized in that the dosage of the aqueous polyurethane is 8 parts.
5. medical latex film as described in claim 1, which is characterized in that the dosage of the antioxidant is 0.5 part.
6. medical latex film as described in claim 1, which is characterized in that the dosage of the natural emulsion is 85 parts.
7. medical latex film as claimed in claim 1 or 5, which is characterized in that the content of catechin is 50%- in tea polyphenols 70%.
8. medical latex film as described in claim 1, which is characterized in that the dosage of the antilubricant is 3 parts.
9. medical latex film as claimed in claim 1 or 8, which is characterized in that the content of Glycolic acid is 40%- in tartaric acid 60%.
10. a kind of preparation method of medical latex film, which is characterized in that preparation method includes the following steps:
(1) each component is put into reaction kettle, 90-100 DEG C is heated in nitrogen atmosphere, in the revolving speed of 100-120r/min Under be stirred continuously, react 2-3h, obtain preform;
(2) by preform made from step (1) be sent into double screw extruder, 175-185 DEG C of extrusion temperature, screw speed 40- 45Hz, twin-screw extrusion batten is water cooled, air-dried, pelletizing, obtains master batch;
(3) master batch obtained by step (2) is squeezed out into blown film in plastic film blowing machine to get medical film is arrived.
CN201810746351.5A 2018-07-09 2018-07-09 Medical latex film and preparation method thereof Withdrawn CN109021331A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810746351.5A CN109021331A (en) 2018-07-09 2018-07-09 Medical latex film and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810746351.5A CN109021331A (en) 2018-07-09 2018-07-09 Medical latex film and preparation method thereof

Publications (1)

Publication Number Publication Date
CN109021331A true CN109021331A (en) 2018-12-18

Family

ID=64640803

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810746351.5A Withdrawn CN109021331A (en) 2018-07-09 2018-07-09 Medical latex film and preparation method thereof

Country Status (1)

Country Link
CN (1) CN109021331A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114276476A (en) * 2021-12-31 2022-04-05 中国热带农业科学院橡胶研究所 Method for improving plasticity retention index of natural rubber

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104448739A (en) * 2014-11-25 2015-03-25 苏州市贝克生物科技有限公司 Composite medical chitosan/ polycaprolactone film and preparation method thereof
CN104877332A (en) * 2015-05-22 2015-09-02 苏州市贝克生物科技有限公司 Method for preparing medical film
CN106519335A (en) * 2016-11-17 2017-03-22 无锡市长安曙光手套厂 Medical latex film

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104448739A (en) * 2014-11-25 2015-03-25 苏州市贝克生物科技有限公司 Composite medical chitosan/ polycaprolactone film and preparation method thereof
CN104877332A (en) * 2015-05-22 2015-09-02 苏州市贝克生物科技有限公司 Method for preparing medical film
CN106519335A (en) * 2016-11-17 2017-03-22 无锡市长安曙光手套厂 Medical latex film

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114276476A (en) * 2021-12-31 2022-04-05 中国热带农业科学院橡胶研究所 Method for improving plasticity retention index of natural rubber

Similar Documents

Publication Publication Date Title
CN106046396B (en) Can rehydration polyoses grain and cavernous body
CN101717530B (en) Natural rubber liquid slurry containing chitosan/sericin and preparation method thereof
CN103319735B (en) Konjac glucomannan antibacterial preservative film
CN101862470A (en) Bacteriostatic hydrocolloid dressing and preparation method thereof
CN108066805A (en) A kind of bionical bacteriostatic film of epsilon-polylysine and its preparation and application
CN102020790B (en) Natural polymer film material with adjustable degradation rate and preparation method
JPH0776241B2 (en) Amorphization of aminopolysaccharides and their derivatives with acids
CN101381906A (en) Alginate nano Ag antibacterial fiber and method for making same
CN111588902A (en) Large-area wound first-aid dressing and preparation method thereof
CN105477674A (en) Hemostasis composite material based on chitosan and marine mussel mucin and preparation method of hemostasis composite material
CN108752610A (en) A kind of edibility antibacterial film and preparation method thereof of sustained release essential oil
CN108926428A (en) Hydrocolloid applies core and preparation method thereof, bearing hydrocolloid dressing and application thereof
CN112717194A (en) Degradable chitosan-based composite hemostatic film
CN110974731A (en) Plukenetia volubilis linneo oil nanofiber membrane for promoting skin repair and preparation method thereof
CN109021331A (en) Medical latex film and preparation method thereof
CN104257620B (en) A kind of chitosan gel rubber dripping pill antibacterial for gynaecology and preparation method thereof
CN104208741A (en) Chitosan based adhesive bandage
Sharma et al. A bio-inspired exploration of eco-friendly bael gum and guar gum-based bioadhesive as tackifiers for packaging applications
CN109320701B (en) Preparation method of degradable fruit and vegetable antibacterial freshness protection package based on modified polylactic acid
CN107970133A (en) Antiseptic toothpaste preparation method and products thereof and application
CN107789661A (en) A kind of hemostatic and antibacterial nanometer film and preparation method thereof
CN112724475A (en) Chitosan/nano montmorillonite/akebia trifoliata peel extract antibacterial film and preparation method and application thereof
KR101451846B1 (en) Mixture composition for functional packaging or containers, food packaging, food container and its manufacturing method
CN108578749A (en) A kind of medical compound pomelo-pectin sponge dressing and its preparation method and application of medicine-carried sustained release
CN108587018A (en) A kind of special polyvinyl alcohol preservative film of strawberry packaging

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20181218